✦ LIBER ✦

The Tolerability, Pharmacokinetics and Pharmacodynamics of Increasing Intravenous Doses of 619C89, a Novel Compound for the Acute Treatment of Stroke, in Healthy Volunteers

✍ Scribed by A. J. MERCER; R. J. LAMB; Z. HUSSEIN; S. HOBBIGER; J. POSNER

Book ID: 119871461
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 106 KB
Volume: 765
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1995.tb16603.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A review of the pharmacokinetics, tolera

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

✍ P. Rosenzweig; M. Canal; A. Patat; L. Bergougnan; I. Zieleniuk; G. Bianchetti 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Amisulpride binds selectively to dopamine D(2) and D(3) receptors in the limbic system. Low doses of amisulpride preferentially block presynaptic D(2)/D(3)-dopamine autoreceptors, thereby enhancing dopaminergic transmission, whereas higher doses block postsynaptic receptors, thus inhibiting dopamine

The tolerability and pharmacokinetics of

The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers

✍ E. SEABER; N. ON; S. PHILLIPS; R. CHURCHUS; J. POSNER; P. ROLAN 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Clinical Safety, Tolerability, Pharmacok

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

✍ Ogata, Koichiro; Mendell-Harary, Jeanne; Tachibana, Masaya; Masumoto, Hiroshi; O 📂 Article 📅 2010 🏛 Sage Publications 🌐 English ⚖ 344 KB

Pharmacokinetics, pharmacodynamics, and

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

✍ Ronald Christopher; Paul Covington; Michael Davenport; Penny Fleck; Qais A. Mekk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Pharmacokinetics, pharmacodynamics, and

Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers.

✍ Andreotti, A C; Pianezzola, E; Persiani, S; Pacciarini, M A; Strolin Benedetti, 📂 Article 📅 1995 🏛 Endocrine Society 🌐 English ⚖ 603 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers

✍ B. Jansen; U. Graselli; S. Dallinger; B. Kiss; V. Wacheck; H. Schlagbauer-Wadl; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 103 KB